1. Home
  2. PGY vs COLL Comparison

PGY vs COLL Comparison

Compare PGY & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$24.83

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$47.68

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
COLL
Founded
2016
2002
Country
United States
United States
Employees
N/A
357
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PGY
COLL
Price
$24.83
$47.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$39.86
$45.40
AVG Volume (30 Days)
4.0M
589.2K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$1,245,946,000.00
$757,067,000.00
Revenue This Year
$28.75
$26.35
Revenue Next Year
$17.23
$3.67
P/E Ratio
N/A
$29.48
Revenue Growth
28.33
26.34
52 Week Low
$8.27
$23.23
52 Week High
$44.99
$48.37

Technical Indicators

Market Signals
Indicator
PGY
COLL
Relative Strength Index (RSI) 49.27 74.26
Support Level $22.61 $45.82
Resistance Level $25.25 $48.37
Average True Range (ATR) 1.45 1.39
MACD 0.44 -0.09
Stochastic Oscillator 89.92 89.52

Price Performance

Historical Comparison
PGY
COLL

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: